Effect of preoperative anxiety on the postoperative quality of recovery after ciprofol-based and propofol-based total intravenous anesthesia in patients undergoing hysteroscopic surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400079916

Enrollment

Unknown

Registered

2024-01-16

Start date

2024-01-22

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preoperative anxiety in patients undergoing hysteroscopic surgery

Interventions

Anxiety+ciprofol group :Ciprofol and sufentanil are used as anesthetic agents

Anxiety+propofol group :propofol and sufentanil are used as anesthetic agents

No anxiety+ ciprofol group :Ciprofol and sufentanil are used as anesthetic agents

No anxiety+ propofol group:propofol and sufentanil are used as anesthetic agents

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Outpatients undergoing painless hysteroscopic surgery; 2.ASA scale =3;

Exclusion criteria

Exclusion criteria: 1.<18 years old; 2. History of allergy to egg, soy oil and narcotic drugs used in this study; 3. Severe cardiopulmonary disease; 4. Epilepsy, mental illness or family history of mental illness; 5. sleep apnea; 6. Difficult Airway; 7. Inability to communicate.

Design outcomes

Primary

Measure	Time frame
Quality of postoperative recovery;	—

Secondary

Measure	Time frame
Dosage of narcotic drug;Times to consciousness recovery;Postoperative resuscitation time;Incidence of nausea and vomiting;Incidence of cardiopulmonary adverse events;	—

Countries

China

Contacts

Public ContactQingtian Geng

The First Affiliated Hospital of USTC

4898074@qq.com+86 133 4920 9485

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026